Menu Search
Equities

Welby Inc

4438:TYO

Welby Inc

Actions
Health CareHealth Care Providers
  • Price (JPY)422.00
  • Today's Change3.00 / 0.72%
  • Shares traded1.90k
  • 1 Year change-16.27%
  • Beta2.1741
Data delayed at least 20 minutes, as of Sep 24 2024 04:56 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year Welby Inc's revenues fell -45.24%from 1.05bn to 575.50m. In addition, the company has been unable to reduce the cost of goods sold, selling, general and administrative expenses and interest paid (all as a percentage of sales). This has contributed to a reduction in net income from a gain of 33.91m to a loss of 505.29m.
Gross margin69.20%
Net profit margin-99.47%
Operating margin-98.75%
Return on assets-38.89%
Return on equity-46.97%
Return on investment-47.39%
More ▼

Cash flow in JPYView more

In 2023, Welby Inc increased its cash reserves by 6.32%, or 52.54m. Cash Flow from Financing totalled 341.25m or 59.30% of revenues. In addition the company used 174.33m for operations while cash used for investing totalled 114.39m.
Cash flow per share-67.88
Price/Cash flow per share--
Book value per share156.88
Tangible book value per share130.17
More ▼

Balance sheet in JPYView more

Welby Inc appears to have little financial risk as the company holds a substantial amount of cash on its books. In fact, 0.26% of the market capitalization can be attributed to its 883.36m and debt could be paid in full if management chose.
Current ratio3.84
Quick ratio3.79
Total debt/total equity0.1542
Total debt/total capital0.1303
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.